AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $106,000 | -70.7% | 15,531 | -65.3% | 0.00% | -100.0% |
| Q4 2021 | $362,000 | -10.6% | 44,758 | +8.4% | 0.00% | -50.0% |
| Q3 2021 | $405,000 | +45.7% | 41,286 | -0.1% | 0.00% | +100.0% |
| Q2 2021 | $278,000 | -33.5% | 41,336 | -10.7% | 0.00% | -50.0% |
| Q1 2021 | $418,000 | +164.6% | 46,286 | +95.7% | 0.00% | +100.0% |
| Q4 2020 | $158,000 | -56.8% | 23,655 | -83.3% | 0.00% | -75.0% |
| Q4 2018 | $366,000 | -63.4% | 141,856 | -37.7% | 0.00% | -55.6% |
| Q3 2018 | $999,000 | -17.8% | 227,573 | +14.8% | 0.01% | -25.0% |
| Q2 2018 | $1,215,000 | -14.6% | 198,223 | +1.5% | 0.01% | -14.3% |
| Q1 2018 | $1,423,000 | -8.7% | 195,223 | +2.8% | 0.01% | -12.5% |
| Q4 2017 | $1,558,000 | -25.8% | 189,973 | -5.0% | 0.02% | -33.3% |
| Q3 2017 | $2,100,000 | – | 199,976 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |